Evaluation of gentamicin therapy in newborns at a community hospital and development of simple dosing guidelines

John E Murphy, Jean T. Carter

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

This study evaluated dosing and pharmacokinetics of gentamicin in neonates at a 600-bed community hospital. Pharmacokinetic data were used to predict steady-state gentamicin drug concentration measurements (DCMs) that the original and five simple alternative dosing regimens (2.5 mg/kg q16h, 2.5 mg/kg q18h, 3 mg/kg q24h, 3.5 mg/kg q24h, and 4 mg/kg q24h) would produce. Fifty infants with DCMs were divided into three groups based on gestational age and two weight groups to examine differences in pharmacokinetics, Gentamicin t1/2 was 8.1 (± 3.4) hours, V was 0.54 (± 0.20) L/kg, k was 0.10 (± 0.04) hours-1, and CL was 0.05 (± 0.02) L/h/kg. The percent (n = 50) of infants with DCMs in a therapeutic range-defined as peak concentrations of 4 to 8 mg/L and trough concentrations less than 2 mg/L-were 46%, 59%, 74%, 78%, 64%, and 32% for the original 2.5 mg/kg q16h, 2.5 mg/kg q18h, 3 mg/kg q24h, 3.5 mg/kg q24h, and 4 mg/kg q24h dosing methods, respectively.

Original languageEnglish (US)
Pages (from-to)1283-1289
Number of pages7
JournalHospital Pharmacy
Volume31
Issue number10
StatePublished - Oct 1996

Fingerprint

Social Planning
Pharmacokinetics
Community Hospital
Gentamicins
Newborn Infant
Guidelines
Pharmaceutical Preparations
Hospital beds
Gestational Age
Therapeutics
Weights and Measures

Keywords

  • aminoglycosides
  • drug concentration measurement
  • gentamicin

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Evaluation of gentamicin therapy in newborns at a community hospital and development of simple dosing guidelines. / Murphy, John E; Carter, Jean T.

In: Hospital Pharmacy, Vol. 31, No. 10, 10.1996, p. 1283-1289.

Research output: Contribution to journalArticle

@article{2a0fdbebb3f04cd88dbcb61b7a78c102,
title = "Evaluation of gentamicin therapy in newborns at a community hospital and development of simple dosing guidelines",
abstract = "This study evaluated dosing and pharmacokinetics of gentamicin in neonates at a 600-bed community hospital. Pharmacokinetic data were used to predict steady-state gentamicin drug concentration measurements (DCMs) that the original and five simple alternative dosing regimens (2.5 mg/kg q16h, 2.5 mg/kg q18h, 3 mg/kg q24h, 3.5 mg/kg q24h, and 4 mg/kg q24h) would produce. Fifty infants with DCMs were divided into three groups based on gestational age and two weight groups to examine differences in pharmacokinetics, Gentamicin t1/2 was 8.1 (± 3.4) hours, V was 0.54 (± 0.20) L/kg, k was 0.10 (± 0.04) hours-1, and CL was 0.05 (± 0.02) L/h/kg. The percent (n = 50) of infants with DCMs in a therapeutic range-defined as peak concentrations of 4 to 8 mg/L and trough concentrations less than 2 mg/L-were 46{\%}, 59{\%}, 74{\%}, 78{\%}, 64{\%}, and 32{\%} for the original 2.5 mg/kg q16h, 2.5 mg/kg q18h, 3 mg/kg q24h, 3.5 mg/kg q24h, and 4 mg/kg q24h dosing methods, respectively.",
keywords = "aminoglycosides, drug concentration measurement, gentamicin",
author = "Murphy, {John E} and Carter, {Jean T.}",
year = "1996",
month = "10",
language = "English (US)",
volume = "31",
pages = "1283--1289",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "10",

}

TY - JOUR

T1 - Evaluation of gentamicin therapy in newborns at a community hospital and development of simple dosing guidelines

AU - Murphy, John E

AU - Carter, Jean T.

PY - 1996/10

Y1 - 1996/10

N2 - This study evaluated dosing and pharmacokinetics of gentamicin in neonates at a 600-bed community hospital. Pharmacokinetic data were used to predict steady-state gentamicin drug concentration measurements (DCMs) that the original and five simple alternative dosing regimens (2.5 mg/kg q16h, 2.5 mg/kg q18h, 3 mg/kg q24h, 3.5 mg/kg q24h, and 4 mg/kg q24h) would produce. Fifty infants with DCMs were divided into three groups based on gestational age and two weight groups to examine differences in pharmacokinetics, Gentamicin t1/2 was 8.1 (± 3.4) hours, V was 0.54 (± 0.20) L/kg, k was 0.10 (± 0.04) hours-1, and CL was 0.05 (± 0.02) L/h/kg. The percent (n = 50) of infants with DCMs in a therapeutic range-defined as peak concentrations of 4 to 8 mg/L and trough concentrations less than 2 mg/L-were 46%, 59%, 74%, 78%, 64%, and 32% for the original 2.5 mg/kg q16h, 2.5 mg/kg q18h, 3 mg/kg q24h, 3.5 mg/kg q24h, and 4 mg/kg q24h dosing methods, respectively.

AB - This study evaluated dosing and pharmacokinetics of gentamicin in neonates at a 600-bed community hospital. Pharmacokinetic data were used to predict steady-state gentamicin drug concentration measurements (DCMs) that the original and five simple alternative dosing regimens (2.5 mg/kg q16h, 2.5 mg/kg q18h, 3 mg/kg q24h, 3.5 mg/kg q24h, and 4 mg/kg q24h) would produce. Fifty infants with DCMs were divided into three groups based on gestational age and two weight groups to examine differences in pharmacokinetics, Gentamicin t1/2 was 8.1 (± 3.4) hours, V was 0.54 (± 0.20) L/kg, k was 0.10 (± 0.04) hours-1, and CL was 0.05 (± 0.02) L/h/kg. The percent (n = 50) of infants with DCMs in a therapeutic range-defined as peak concentrations of 4 to 8 mg/L and trough concentrations less than 2 mg/L-were 46%, 59%, 74%, 78%, 64%, and 32% for the original 2.5 mg/kg q16h, 2.5 mg/kg q18h, 3 mg/kg q24h, 3.5 mg/kg q24h, and 4 mg/kg q24h dosing methods, respectively.

KW - aminoglycosides

KW - drug concentration measurement

KW - gentamicin

UR - http://www.scopus.com/inward/record.url?scp=0029970721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029970721&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 1283

EP - 1289

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 10

ER -